who offers tirzepatide Something New. Something More Effective. We're excited to now offer as part of our medically supervised weight loss program. Why this matters: ✓ Targets both GLP-1 & GIP pathways ✓ Supports Tirzepatide Microdose Program – Healthogenics
Description
Randomized controlled trials (RCTs) comparing insulin with established GLP-1 RAs, DPP-4is, or SGLT-2is were included
Among the individual GLP-1RAs assessed, the largest reductions in CV risk, HbA1c, and weight outcomes were observed with combination therapy with SGLT2i and once weekly semaglutide for T2D
But the study had 108 patients, all with HIV
Semaglutide, GLP-1 & custom programs with expert guidance
